Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
16,86 USD | -0,06% | +8,08% | +13,23% |
Attività
Numero di dipendenti: 72
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Jaume Pons
FOU | Founder | 58 | 01/04/15 |
Jason Lettmann
CEO | Chief Executive Officer | 46 | 01/04/20 |
Peter García
DFI | Director of Finance/CFO | 62 | 01/01/20 |
Chief Tech/Sci/R&D Officer | - | 01/11/21 | |
Sophia Randolph
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/06/16 |
Michael Chang
COO | Chief Operating Officer | - | 01/03/15 |
Shelly Pinto
AUD | Comptroller/Controller/Auditor | 48 | 03/05/21 |
Hong I. Wan
PRN | Corporate Officer/Principal | - | 01/04/15 |
Hank Stern
PRN | Corporate Officer/Principal | - | 01/01/15 |
Chris Byrd
LAW | General Counsel | - | 01/05/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
J. Garland
BRD | Director/Board Member | 55 | 28/11/22 |
Corey Goodman
CHM | Chairman | 72 | 01/03/15 |
Jack Nielsen
BRD | Director/Board Member | 60 | 01/04/20 |
Jason Lettmann
CEO | Chief Executive Officer | 46 | 01/04/20 |
Rekha Hemrajani
BRD | Director/Board Member | 54 | 01/04/20 |
Jaume Pons
FOU | Founder | 58 | 01/04/15 |
Sophia Randolph
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/06/16 |
Itziar Canamasas
BRD | Director/Board Member | 50 | 11/04/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 50 498 816 | 39 460 945 ( 78,14 %) | 0 | 78,14 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+13,23% | 851 Mln | |
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,74 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione ALXO
- Società ALX Oncology Holdings Inc.